AzTrials
AzTrials

Knee InjuriesNCT03053453

Evaluation of Patient Reported Outcomes (PRO) After Total Knee Arthroplasty (TKA) Under Spinal Anesthesia

A study testing Spinal Surgery and Verasense Knee System device in people with Knee Injuries, run by NYU Langone Health at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study will be to evaluate and compare patients undergoing total knee arthroplasty (TKA) with sensor guidance versus that of a standard technique. Each patient will be assessed for the difference between passive, soft tissue controlled, pressure balance and muscle activated pressure balance. Read more about this study

Who is it for?
Ages 50 years and older
Conditions the study is for
Knee Injuries
What is being tested?
Spinal Surgery and Verasense Knee System device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 siteUnited States
Study dates
6 Dec 2016to 13 Jul 2022
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients will be screened for eligibility based on whether they have chronic knee pain as a result of an arthritis-related condition.
  • Patient with chronic knee pain who is indicated for total hip or knee replacement surgery
  • Patient is at least 50 years of age
  • Patient is willing to participate in pre- and postoperative surveys

Who cannot join

  • Failure to complete pre-operative surveys.
  • Revision Total Knee Arthroplasty
  • Prior ipsilateral knee surgery such as ligament reconstruction or osteotomy
  • Contralateral Total Knee Arthroplasty
  • Prior tibial plateau fracture
  • Ligamentous Insufficiency
  • History of fibromyalgia, chronic fatigue syndrome

Trial locations and contacts

1 site in 1 country.

United States1 site
  • New York University School of Medicine

    New York, New York, 10016

Other trials in United States

About this study

Official title: Evaluation of the Patient Reported Outcomes After Sensor-guided Total Knee Arthroplasty Under Spinal Anesthesia With Limited Motor-block.

The purpose of this study will be to evaluate and compare patients undergoing total knee arthroplasty (TKA) with sensor guidance versus that of a standard technique. Each patient will be assessed for the difference between passive, soft tissue controlled, pressure balance and muscle activated pressure balance.

Conditions
Knee Injuries
Being tested
Spinal Surgery, Verasense Knee System device
Keywords
Total Knee Replacement Arthroplasty
Medical subject headings
Knee Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Spinal SurgeryProcedure or surgery

    TKA under standard of care spinal surgery.

  • Verasense Knee System deviceDevice

    Also called OrthoSensor

    Sensor measures and localizes peak load at the medial and lateral tibiofemoral joint interfaces. Loading data is thereby captured intra-operatively through the full range of movement (ROM) using the sensor system.

Study groups in NCT03053453
Study groupRoleWhat they receive
Standard of Care Spinal SurgeryActive comparatorPatients will be given spinal anesthesia with 2.6 mL of 0.5% isobaric bupivacaine.
Receives: Procedure: Spinal Surgery
Sensor Guided Spinal SurgeryExperimentalThe Verasense Knee System device (OrthoSensor inc., Dania Beach, Florida) is a sterile sensor system that replaces the tibial insert trials used during surgery. The sensor contains a microprocessor and integrated nanosensor system, which wirelessly transmits real-time data to a portable graphic display unit used for read-out of the data. The sensor measures and localizes peak load at the medial and lateral tibiofemoral joint interfaces. Loading data is thereby captured intra-operatively through the full range of movement (ROM) using the sensor system.
Receives: Device: Verasense Knee System device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knee Society Score (KSS)

    The Knee Society Score (KSS) comprises two sections (each worth 100 points) for a maximum 200 points. One section is the Knee Society Clinical Score (KSCS) - points are given for pain, motion, and stability and points are deducted for flexion contracture, extension lag, and misalignment. The other section is the Knee Society Functional Score (KSFS) - points are assigned for walking distances and climbing stairs and points are deducted for use of walking aids. For each section, a score of 80-100 = excellent, 70-79 = good; 60-69 = fair; and < 60 = poor.

    Measured: Month 12 Post-Surgery

  2. Knee Injury and Osteoarthritis Outcome Score (KOOS)

    The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a self-reported outcome measure assessing the patient's opinion about the health, symptoms, and functionality of their knee. It is a 42-item questionnaire, including 5 subscales: symptoms, pain, function in daily living (ADLs), sports/recreation, and quality of life. The maximum score a patient can achieve is 100, indicating no knee problems. The minimum score is zero, indicating severe knee problems.

    Measured: Month 12 Post-Surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2017
  2. Study start6 Dec 2016
  3. Primary completion13 Jul 2022
  4. Study completion13 Jul 2022

Why it stopped: Departure of study surgeon investigator.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a randomized prospective study looking at the impact sensor guidance has on the outcome of patients and comparing to that of patients with a standard technique.
Masking
None (open label)
Enrolment
52 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03053453
Sponsor's protocol ID
16-00129
Status last verified
Oct 2023
First submitted
30 Jan 2017
Last updated
14 Nov 2023
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Spinal Surgery and Verasense Knee System device in people with Knee Injuries, run by NYU Langone Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 14 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 14 Nov 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knee Society Score (KSS) (time frame: Month 12 Post-Surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in